Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Entertainment
  • Business
  • Real Estate
  • Technology
  • Health
  • Non-profit
ncarol.com

3i Solutions Announces New Leadership Brings a Customer-Focused Approach
ncarol.com/10185117

Trending...
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 122
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 114
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 114
26-171491
CARTHAGE, Mo. - ncarol.com -- 3i Solutions, in conjunction with partner Stratum Nutrition® (a business of ESM Technologies), is pleased to announce the addition of two new roles, Director of Finance and Director of Business Development, both of which will bring an extensive amount of expertise to each department.

Brian Reich, Director of Finance at 3i Solutions, comes to the company with an extensive
background in supply chain management, manufacturing operations, customer service, and estimating his skill set will help add value and profitability to our customer's bottom line. He was formerly a Director of Operations for several companies, most notably 20 years at Milark Industries.

"I am very fortunate to have the opportunity to be a part of the 3i team," said Brian "This group is strong, and I look forward to helping the company expand into new markets while continuing to deliver a high level of customer service and value to our customers."

Becky Wagner, Director of Business Development at 3i Solutions, brings 25 years of experience in the food, beverage, health care, and pet care industry, delivering solutions to help customers drive their products to market faster through market development activities creating new products offerings, optimizing current offerings or identify key growth areas to expand the portfolio. She was formerly the VP of Growth Platforms at FONA International.

More on ncarol.com
  • Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
  • Lake Norman Philharmonic Annual Holiday Concert 2026
  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
  • Philadelphia-Area Entrepreneur Nouho M Kanneh Builds $37 Million Net Worth Across Real Estate, E-Commerce and Retail

"I am blessed to have the opportunity to be part of the 3i team," said Becky "The technology that we have is a game changer for so many products, and I can't wait to explore the many new products that will delight consumers with better efficacy and availability of materials in new formats."

Scott Peters, Director of Product Development at 3i Solutions, said, "In this rapidly changing world, we at 3i Solutions realize that we must stay at the forefront of our industry by providing a quality product at a cost-effective price, and the best way to do this is to build an exceptional team. I have known and worked with Becky and Brian for several years in and out of our industry. I could not be happier that they decided to join 3i Solutions. Their expertise combined with an already exceptional 3i team strengthens our company ensuring that our future looks bright and productive."

##

About 3i Solutions:
Ingredient Innovations International Company, dba 3i Solutions was founded to develop and manufacture ingredients for consumer markets utilizing 3i Solutions' proprietary encapsulation technologies. Our management team has years of experience in food & health care product development, product management, sales management, and chemistry. Our experience creates value as we work with our customers to develop new ingredients to incorporate into consumer preferred products.

More on ncarol.com
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • The World's No.1 Superstar® Brings Christmas Back in Grand Style with Music, Cinematic Glamour, and Luxury Fashion
  • New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
  • Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board

3i Solutions makes new products possible by transforming water insoluble ingredients to water dispersible formats. Utilizing 3i Solutions technology, one can achieve water dispersible CBD, fish oil omegas, plant-based omegas, vitamin D, CoQ10, carotenoids and much more. Our formulation expertise & technology can be used for water enhancing drops, ready to drink liquids and even topical formulations where it can help keep certain ingredients be encapsulated and not absorbed. 3i Solutions' technology delivers ingredients that stay suspended in a water-based solution with clinically proven bioavailability improvement compared to traditional forms (i.e. CoQ10 study providing significant support of cardiovascular and muscle health). Further examples of 3i Solutions' bioavailability advantages are currently being studied and will be shared at this year's SupplySide West Expo in November.

About Stratum Nutrition
Stratum Nutrition®, a business of ESM Technologies, LLC, is a trusted ingredient innovator and supplier to product formulators for human and pet health. Stratum offers a portfolio of
research-supported ingredients and technology that stand out in their respective health
categories as being progressive, safe, and effective, including NEM® brand eggshell membrane, Eggshell Membrane Collagen Support Complex, LBiome™ Lactobacillus LB postbiotic, Ahiflower®, BLIS K12®, BLIS M18®, VitaSperse® ingredient delivery technology, NatAxtin™ astaxanthin, Curcumin 95, curQplus®, and ESC® brand eggshell calcium. These trusted ingredients are relied upon by consumers internationally. Visit http://www.stratumnutrition.com for more information.

Contact
David Hoover
***@stratumnutrition.com


Source: Stratum Nutrition
Filed Under: Technology

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Tonight in Asheville: KayeDinero Drops "Underground" and Opens Beat Catalog
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Prince's Collaborator Shelby J To Be A Special Guest For "a Deadly Proposal" Red Carpet
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • 7th Annual RACE INDUSTRY WEEK Returns Nov. 30 – Dec. 3 With Free Live Webinars From Racing Leaders
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • AQUALIS of Morrisville, NC, Acquires Full Circle Environmental of Garner, NC
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
_catLbl0 _catLbl1

Popular on ncarol.com

  • Parade of Homes Winners Announced - 252
  • Nious Media Expands Independent Entertainment Network Through Gaming, Music and Digital Storytelling - 191
  • North Carolina Author Carrie Sybert Celebrates Three Published Books - 181
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton - 127
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 122
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST) - 116
  • Kestrel Ridge Health Launches AI-Powered Ophthalmology Workforce Forecasting Platform - 114
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs - 114
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options - 113
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology - 111

Similar on ncarol.com

  • Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
  • Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
  • Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute